CC BY 4.0 · Indian J Med Paediatr Oncol 2023; 44(04): 398-407
DOI: 10.1055/s-0043-1768050
Review Article

Metacognitive Processes in Cancer: A Review

1   Centre for Health Psychology, University of Hyderabad, Hyderabad, India
Chhakchhuak Vanlalhruaii
1   Centre for Health Psychology, University of Hyderabad, Hyderabad, India
› Author Affiliations


When diagnosed with cancer, the patients and their family go through emotional turmoil across the different phases: diagnosis, assessment, treatment, and aftercare, which decrease their quality of life and well-being. Previously, many studies have highlighted the association of metacognition with the development and maintenance of mental health conditions. Several recent studies have pointed out the significant role of dysfunctional metacognitive beliefs in the context of chronic disease. Thus, the present study aims to explore the role of metacognitive processes in cancer. The researchers conducted a narrative review of literature using PubMed, Semantic Scholar, and Science Direct. A total of 31 articles were selected and analyzed. This review article established that patients with cancer and caregivers experience metacognitive beliefs, which are associated with emotional distress, and the effectiveness of metacognitive therapy in reducing distress. This study also provides insight into the broader scope to advance research in this field.

Publication History

Article published online:
24 April 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Baker L. Metacognition. In: Peterson P, Baker E, McGaw B. eds. International Encyclopaedia of Education. 3rd ed.. Amsterdam: Elsevier; 2010: 204-210
  • 2 Flavell JH. Metacognitive Aspects of Problem Solving. Resnick LR. ed. Mahwah, NJ: Lawrence Erbaum; 1976
  • 3 Aurah CM, Koloi-Keaikitse S, Isaacs C, Finch H. The role of metacognition in everyday problem solving among primary students in Kenya. Probl Educ 21st Century 2011; 30: 9-21
  • 4 Basu S, Dixit S. Role of metacognition in explaining decision-making styles: a study of knowledge about cognition and regulation of cognition. Pers Individ Dif 2022; 185: 111318
  • 5 Yeung N, Summerfield C. Metacognition in human decision-making: confidence and error monitoring. Philos Trans R Soc Lond B Biol Sci 2012; 367 (1594): 1310-1321
  • 6 Choy SC, Cheah PK. Teacher perceptions of critical thinking among students and its influence on higher education. Int J Teach Learn High Educ 2009; 20 (02) 198-206
  • 7 Matthews G, Hillyard EJ, Campbell SE. Metacognition and maladaptive coping as components of test anxiety. Clin Psychol Psychother 1999; 6 (02) 111-125
  • 8 Hagen R, Hjemdal O, Solem S. et al. Metacognitive therapy for depression in adults: a waiting list randomized controlled trial with six months follow-up. Front Psychol 2017; 8: 31
  • 9 Papageorgiou C, Wells A. Metacognitive beliefs about rumination in recurrent major depression. Cognit Behav Pract 2001; 8 (02) 160-164
  • 10 Wells A. Metacognitive Therapy for Anxiety and Depression. New York, NY: Guilford press; 2011
  • 11 Capobianco L, Faija C, Husain Z, Wells A. Metacognitive beliefs and their relationship with anxiety and depression in physical illnesses: a systematic review. PLoS One 2020; 15 (09) e0238457
  • 12 Lenzo V, Sardella A, Martino G, Quattropani MC. A systematic review of metacognitive beliefs in chronic medical conditions. Front Psychol 2020; 10: 2875
  • 13 Khodabakhshi Koolaee A, Falsafinejad MR, Ghorbani Sakachaei L, Sanagoo A. Relation between metacognitive beliefs and psychological adjustment with improving quality of life in type II diabetic patients. Majallah-i Danishgah-i Ulum-i Pizishki-i Gurgan 2019; 21 (03) 79-87
  • 14 Naser AY, Hameed AN, Mustafa N. et al. Depression and anxiety in patients with cancer: a cross-sectional study. Front Psychol 2021; 12: 585534
  • 15 Riedl D, Schuessler G. Prevalence of depression and cancer - a systematic review. Z Psychosom Med Psychother 2022; 68 (01) 74-86
  • 16 Wells A, Cartwright-Hatton S. A short form of the metacognitions questionnaire: properties of the MCQ-30. Behav Res Ther 2004; 42 (04) 385-396
  • 17 Cartwright-Hatton S, Wells A. Beliefs about worry and intrusions: the Meta-Cognitions Questionnaire and its correlates. J Anxiety Disord 1997; 11 (03) 279-296
  • 18 Tosun A, Irak M. Adaptation, validity, and reliability of the Metacognition Questionnaire-30 for the Turkish population, and its relationship to anxiety and obsessive-compulsive symptoms [in Turkish]. Turk Psikiyatr Derg 2008; 19 (01) 67-80
  • 19 Quattropani MC, Lenzo V, Mucciardi M, Toffle ME. The role of metacognitions in predicting anxiety and depression levels in cancer patients ongoing chemotherapy. Procedia Soc Behav Sci 2015; 205: 463-473
  • 20 Dragan M., Dragan W. Ł. . (2011). Psychometric properties of the Polish version of the Metacognitions Questionnaire-30. Psychiatria polska 45 (04) 545-553
  • 21 Gerlach A, Adam S, Marschke S, Melfsen S. Development and validation of a child version of the Metacognitions Questionnaire. Paper presented at: 38th Annual Congress of the European Association for Behavioural and Cognitive Therapies; Helsinki; September 10–13, 2008
  • 22 Cook SA, Salmon P, Dunn G, Fisher P. Measuring metacognition in cancer: validation of the Metacognitions Questionnaire 30 (MCQ-30). PLoS One 2014; 9 (09) e107302
  • 23 Inci H, Inci F, Ersoy S, Karatas F, Adahan D. Self-esteem, metacognition, and coping strategies in cancer patients: a case-control study. J Cancer Res Ther 2021; 17 (04) 956-962
  • 24 Cherry MG, Salmon P, Byrne A, Ullmer H, Abbey G, Fisher PL. Qualitative evaluation of cancer survivors' experiences of metacognitive therapy: a new perspective on psychotherapy in cancer care. Front Psychol 2019; 10: 949
  • 25 Anderson R, Capobianco L, Fisher P. et al. Testing relationships between metacognitive beliefs, anxiety and depression in cardiac and cancer patients: are they transdiagnostic?. J Psychosom Res 2019; 124: 109738
  • 26 Cook SA, Salmon P, Dunn G, Holcombe C, Cornford P, Fisher P. The association of metacognitive beliefs with emotional distress after diagnosis of cancer. Health Psychol 2015; a 34 (03) 207-215
  • 27 Mutlu HH, Bilican FI, Mutlu HH, Gumus M. A comparison of metacognitive factors among patients with cancer and the control group. Psychooncology 2018; 27 (04) 1277-1283
  • 28 Quattropani MC, Lenzo V, Mucciardi M, Toffle ME. Metacognition as predictor of emotional distress in cancer patients. Life Span Disabil 2016; 19 (02) 221-239
  • 29 Quattropani MC, Lenzo V, Filastro A. Predictive factors of anxiety and depression symptoms in patients with breast cancer undergoing chemotherapy. An explorative study based on metacognitions. J Psychopathol 2017; 23: 67-73
  • 30 Cook SA, Salmon P, Dunn G, Holcombe C, Cornford P, Fisher P. A prospective study of the association of metacognitive beliefs and processes with persistent emotional distress after diagnosis of cancer. Cognit Ther Res 2015; b 39 (01) 51-60
  • 31 Ranieri J, Guerra F, Perilli E, Cilli E, Di Giacomo D. Metacognitions and quality of life in survivorship after breast cancer diagnosis [in Italian]. Riv Psichiatr 2021; 56 (04) 217-222
  • 32 Ranieri J, Guerra F, Di Giacomo D. Role of metacognition thinking and psychological traits in breast cancer survivorship. Behav Sci (Basel) 2020; 10 (09) 135
  • 33 Toffalini E, Veltri A, Cornoldi C. Metacognitive aspects influence subjective well-being in parents of children with cancer. Psychooncology 2015; 24 (02) 175-180
  • 34 Xiao PP, Ding SQ, Duan YL. et al. Metacognitions associated with reproductive concerns: a cross-sectional study of young adult female cancer survivors in China. Front Psychol 2022; 13: 987221
  • 35 Cheli S, Caligiani L, Martella F, De Bartolo P, Mancini F, Fioretto L. Mindfulness and metacognition in facing with fear of recurrence: a proof-of-concept study with breast-cancer women. Psychooncology 2019; 28 (03) 600-606
  • 36 Ng DWL, Foo CC, Ng SSM. et al. The role of metacognition and its indirect effect through cognitive attentional syndrome on fear of cancer recurrence trajectories: a longitudinal study. Psychooncology 2020; 29 (02) 271-279
  • 37 Ağaç M, Üzar-Özçetin YS. Psychological resilience, metacognitions, and fear of recurrence among cancer survivors and family caregivers. Cancer Nurs 2022; 45 (02) E454-E462
  • 38 Thewes B, Bell ML, Butow P. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors. Psychooncology 2013; 22 (09) 2059-2063
  • 39 Ng DWL, Kwong A, Suen D. et al. Fear of cancer recurrence among Chinese cancer survivors: prevalence and associations with metacognition and neuroticism. Psychooncology 2019; 28 (06) 1243-1251
  • 40 Butow P, Kelly S, Thewes B, Hruby G, Sharpe L, Beith J. Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence. Psychooncology 2015; 24 (04) 416-423
  • 41 Fisher PL, Byrne A, Salmon P. Metacognitive therapy for emotional distress in adult cancer survivors: a case series. Cognit Ther Res 2017; 41 (06) 891-901
  • 42 Fisher PL, Byrne A, Fairburn L, Ullmer H, Abbey G, Salmon P. Brief metacognitive therapy for emotional distress in adult cancer survivors. Front Psychol 2019; 10: 162
  • 43 Zahedian E, Bahreini M, Ghasemi N, Mirzaei K. Group meta-cognitive therapy and depression in women with breast cancer: a randomized controlled trial. BMC Womens Health 2021; 21 (01) 111
  • 44 Fisher PL, McNicol K, Young B, Smith E, Salmon P. Alleviating emotional distress in adolescent and young adult cancer survivors: an open trial of metacognitive therapy. J Adolesc Young Adult Oncol 2015; 4 (02) 64-69
  • 45 Javadi THS, Tajikzadeh F, Bayat H, Eshraghi N, Roshandel Z, Rahmani S. Comparison of effectiveness of the mindfulness-based cognitive therapy and the metacognition treatment on anxiety, depression and stress among breast cancer patients. Int Clin Neurosci J 2018; 5 (02) 62-66
  • 46 Rahmani S, Talepasand S, Ghanbary-Motlagh A. Comparison of effectiveness of the metacognition treatment and the mindfulness-based stress reduction treatment on global and specific life quality of women with breast cancer. Iran J Cancer Prev 2014; 7 (04) 184-196
  • 47 Barjoee LK, Amini N, Keykhosrovani M, Shafiabadi A. Effectiveness of positive thinking training on perceived stress, metacognitive beliefs, and death anxiety in women with breast cancer: perceived stress in women with breast cancer. Arch Breast Cancer 2022; 9: 195-203
  • 48 Wolf TJ, Doherty M, Kallogjeri D. et al. The feasibility of using metacognitive strategy training to improve cognitive performance and neural connectivity in women with chemotherapy-induced cognitive impairment. Oncology 2016; 91 (03) 143-152
  • 49 Assis MRD, Maraglia PH, Brandão MAG, Peixoto MAP. Metacognition as an educational technology in self-care learning: the case of prevention of post-surgical lymphedema of breast cancer. Esc Anna Nery 2018;22
  • 50 Geng HM, Chuang DM, Yang F. et al. Prevalence and determinants of depression in caregivers of cancer patients: a systematic review and meta-analysis. Medicine (Baltimore) 2018; 97 (39) e11863
  • 51 Northouse LL, Katapodi MC, Schafenacker AM, Weiss D. The impact of caregiving on the psychological well-being of family caregivers and cancer patients. Semin Oncol Nurs 2012; 28 (04) 236-245
  • 52 Fashler SR, Weinrib AZ, Azam MA, Katz J. The use of acceptance and commitment therapy in oncology settings: a narrative review. Psychol Rep 2018; 121 (02) 229-252
  • 53 Li Z, Li Y, Guo L, Li M, Yang K. Effectiveness of acceptance and commitment therapy for mental illness in cancer patients: a systematic review and meta-analysis of randomised controlled trials. Int J Clin Pract 2021; 75 (06) e13982
  • 54 Zhao C, Lai L, Zhang L. et al. The effects of acceptance and commitment therapy on the psychological and physical outcomes among cancer patients: a meta-analysis with trial sequential analysis. J Psychosom Res 2021; 140: 110304
  • 55 Blumenstein KG, Brose A, Kemp C. et al. Effectiveness of cognitive behavioral therapy in improving functional health in cancer survivors: a systematic review and meta-analysis. Crit Rev Oncol Hematol 2022; 175: 103709
  • 56 Kucherer S, Ferguson RJ. Cognitive behavioral therapy for cancer-related cognitive dysfunction. Curr Opin Support Palliat Care 2017; 11 (01) 46-51
  • 57 Elimimian EB, Elson L, Stone E. et al. A pilot study of improved psychological distress with art therapy in patients with cancer undergoing chemotherapy. BMC Cancer 2020; 20 (01) 899
  • 58 Forzoni S, Perez M, Martignetti A, Crispino S. Art therapy with cancer patients during chemotherapy sessions: an analysis of the patients' perception of helpfulness. Palliat Support Care 2010; 8 (01) 41-48
  • 59 Bradt J, Shim M, Goodill SW. Dance/movement therapy for improving psychological and physical outcomes in cancer patients. Cochrane Database Syst Rev 2015; 1 (01) CD007103
  • 60 Datt KB. Cancer cases likely to go up by over 12% between '20 & '25, says ICMR. The New Indian Express. December 1, 2022. Accessed March 15, 2023 at:
  • 61 Sharma P. India's cancer burden to rise to 29.8 million in 2025: ICMR report. Mint. May 13, 2022. Accessed March 15, 2023 at: